Paige.AI

Contact for Pricing

1 Likes

Twitter

Facebook

Copy Link

Paige is transforming the way pathologists work through a comprehensive digital pathology platform and generative AI applications.

How Paige.AI can help you:

Enhances pathology workflows for efficient and accurate diagnostics.
Provides actionable insights with cutting-edge AI applications.
Supports the full digitization of pathology labs for improved case review and analysis.
Facilitates the detection of molecular biomarkers not typically visible to the human eye.

Why choose Paige.AI: Key features

The first and only company with FDA approval for an AI application in pathology.
Exclusive access to the largest and most diverse dataset in cancer diagnostics.
Comprehensive digital pathology platform with robust AI integration.
Expert support for lab digitization and AI application implementation.

Who should choose Paige.AI:

Pathologists seeking to enhance diagnostic accuracy and efficiency.
Hospitals and labs aiming to integrate digital pathology solutions.
Medical professionals interested in advanced cancer detection and diagnostics.

About Paige.AI

Website

https://paige.ai/

Release Date

March 2024

Pricing

Contact for Pricing

Related fields

Related News

Stanford AI Tool Predicts Cancer Gene Activity from Biopsy Images, Potentially Revolutionizing Cancer Diagnosis

Stanford Medicine researchers have developed an AI-powered tool called SEQUOIA that can predict gene activity in cancer cells using only biopsy images, potentially speeding up diagnosis and treatment decisions while reducing costs.

3 Sources

Fri, 15 Nov, 8:04 AM UTC

AI Breakthrough: Deep Learning Model Revolutionizes Pancreatic Cancer Diagnosis and Treatment

Researchers develop a highly accurate deep learning model for classifying pancreatic ductal adenocarcinoma (PDAC) subtypes using histopathology images, offering a rapid and cost-effective alternative to current molecular profiling methods.

3 Sources

Fri, 13 Dec, 8:08 AM UTC

Mayo Clinic Launches Digital Pathology Platform to Revolutionize Healthcare with AI

Mayo Clinic announces the creation of Mayo Clinic Digital Pathology, a platform designed to leverage AI and vast digital slide archives to transform pathology practices and accelerate medical breakthroughs.

2 Sources

Tue, 14 Jan, 4:01 PM UTC

AI detects colorectal cancer with high accuracy

University of JyväskyläFeb 28 2025 A new AI-based tool for identifying colorectal cancer from tissue sample analysis has been developed at the University of Jyväskylä. The new artificial neural network model has surpassed all its predecessors in classification performance. The tool has also been made freely available. Researchers at the University of Jyväskylä, in collaboration with the University of Turku's Institute of Biomedicine, University of Helsinki and Nova Hospital of Central Finland, have developed an advanced artificial intelligence tool for automatic analysis of colorectal cancer tissue slides. The neural network model developed in the study outperformed all previous models in the classification of tissue microscopy samples. Based on our study, the developed model is able to identify all tissue categories relevant for cancer identification, with an accuracy of 96.74%." Fabi Prezja, Doctoral Student, University of Jyväskylä In practice, the tissue analysis involves a pathologist looking through the scanned digital microscopy slides, prepared from the patient's intestine sample, and marks, point by point, for example, where the cancerous and related tissues are visible. The tool developed in this study could save doctors' time by automating this process. The tool analyses a sample and highlights areas containing different tissue categories.The tool's accuracy has the potential to significantly ease the workload of histopathologists, potentially resulting in faster diagnoses, prognoses and clinical insights. The research team has made the tool freely available and hopes for further breakthroughs in cancer research The research team has made its AI tool freely available to encourage research collaboration. "The free availability aims to accelerate future advances by encouraging scientists, developers and researchers worldwide to continue developing the tool and finding new applications for it." Prezja explains. The research team points out that despite the promising results, the introduction of AI tools to the clinical setting must be done gradually with caution. Before AI solutions can become routine clinical practice, it is essential for them to undergo a rigorous validation process to ensure that the results they produce are consistent with clinical and regulatory standards. University of Jyväskylä Journal reference: Prezja, F., et al. (2025). Improving performance in colorectal cancer histology decomposition using deep and ensemble machine learning. Heliyon. doi.org/10.1016/j.heliyon.2024.e37561

News-Medical

Fri, 28 Feb, 2:30 PM UTC

Aira Matrix and Gestalt partner for AI-powered pathology

AIRA Matrix and Gestalt have forged a strategic partnership to integrate AIRA Matrix's AI-powered quality control solution, AIRAQC, into Gestalt's PathFlow platform. Announced on March 24, 2025, this collaboration aims to boost diagnostic precision and efficiency in labs globally. AIRAQC uses artificial intelligence to streamline quality control, enabling quicker and more precise analysis in pathology. Its integration with Gestalt's system offers pathologists a smooth, AI-enhanced experience that optimizes diagnostic decisions. "We're thrilled to partner with Gestalt to expand the reach of AIRAQC and deliver transformative AI capabilities to pathology labs," said Marco Comianos, Head of Commercial Operations - US., AIRA Matrix. Relativity's aiR now supercharges government document review Lisa-Jean Clifford, Gestalt COO & Chief Strategy Officer, states that the partnership signifies an effort to advance pathology, meeting evolving healthcare needs by providing labs with tools improving diagnostic accuracy, quality and meaningful metrics at the start of the diagnostic process. AIRA Matrix specializes in AI solutions for healthcare and life sciences, offering products that enhance diagnostic accuracy and provide data-driven insights from digital images. Their AI suite aids drug discovery and development by streamlining pre-analytical quality control, tissue triage, and safety assessments. Gestalt focuses on transforming pathology through an intelligent, configurable, and AI-driven digital workflow, PathFlow. This solution offers interoperability, allowing pathologists to diagnose diseases faster and more efficiently by reducing manual tasks.

Dataconomy

Mon, 24 Mar, 4:34 PM UTC

Similar products

Tempus

Tempus leverages AI-enabled precision medicine to transform patient care by making clinical and molecular data accessible and useful.

Contact for Pricing

Oatmeal Health

Oatmeal Health leverages AI technology for early cancer detection, focusing on lung and breast cancer screenings for marginalized communities.

Contact for Pricing

Pth.AI

Pth.AI - Transforming business goals with AI-driven insights and personalized action plans.

Contact for Pricing

BenevolentAI

BenevolentAI utilizes AI to accelerate drug discovery, enhancing scientific innovation and the likelihood of discovering successful drugs.

Contact for Pricing

Insightai.dev

Leverage the power of AI for medical research with Insightai.dev, a pioneering research studio designed to enhance your medical studies in seconds.

Contact for Pricing

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

The Outpost

Top stories

News

About